Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Devon V. Adams"'
Publikováno v:
Personalized Medicine. 19:171-180
Aim: Commercial plan coverage policies for multigene panel tests may vary and could result in geographic variation in coverage due to the fragmented nature of the commercial insurance market. This study aimed to characterize the alignment of multigen
Publikováno v:
JAMA network open. 5(7)
Logistical challenges such as travel time and distance to a clinical trial site can be a barrier to patient participation. The association of remote technology use and other decentralization tools that can reduce these barriers with likelihood to enr
Autor:
Gelareh Sadigh, Hilary Gee Goeckner, Ella A. Kazerooni, Bruce E. Johnson, Robert A. Smith, Devon V. Adams, Ruth C. Carlos
Publikováno v:
CancerREFERENCES. 128(15)
Comprehensive biomarker testing has become the standard of care for informing the choice of the most appropriate targeted therapy for many patients with advanced cancer. Despite evidence demonstrating the need for comprehensive biomarker testing to e
Autor:
Daniel M. Sheinson, William B. Wong, Craig S. Meyer, Stella Stergiopoulos, Katherine T. Lofgren, Carlos Flores, Devon V. Adams, Mark E. Fleury
Publikováno v:
JAMA Network Open
Key Points Question Is the implementation of the Medicare national coverage determination (NCD) associated with use of next-generation sequencing by insurance and racial and ethnic categories? Findings In this cohort study of 92 687 patients with lun